Click HERE to download the PDF version

As an expert parenteral CDMO, Grifols Partnership is aware that the high cost of manufacturing injectable drugs, as well as quality issues and compliance requirements, forces companies to outsource these products. For an increasing number of companies, seeking technically and operationally superior contract-service partners to deliver capacity and resources is becoming a key component of their patient-centric strategy and the fastest path to market.

WHAT SETS GRIFOLS PARTNERSHIP APART FROM OTHER CDMOS IN THE INJECTABLE FIELD?

Our commitment with customers and credibility has positioned Grifols Partnership as a reliable and trusted partner in the injectable field.

From both a commercial and production perspective, we have historically invested in the delivery of safe and high-quality ... ...